The landscape of dementia analysis has advanced significantly with the arrival of subtle biomarkers, such as amyloid PET scans, tau imaging, and blood-based mostly assessments which can detect Alzheimer's pathology many years just before indicators arise. When these technological innovations represent outstanding progress in knowing neurodegenerati